Oxygen dosing during surgery may reduce lung complications
NCT ID NCT06013098
First seen Mar 24, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
This study looked at whether using different oxygen concentrations during and after esophageal cancer surgery could lower the risk of lung collapse (atelectasis). 65 patients were randomly assigned to receive either 30% or 60% oxygen during two-lung ventilation. The main goal was to see how often lung collapse occurred after surgery, measured by CT scan. The results could help guide oxygen use in the operating room.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oxygen
What this could lead to
If successful, this could help doctors choose the best oxygen levels during surgery to reduce lung problems after esophageal cancer removal.
What could go wrong
This is a small, completed Phase 4 trial with only 65 participants. Results may not apply to all patients or surgeries, and the benefit may be small.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.